Blood Pressure Medication Recall: A Potential Health Hazard
The Food and Drug Administration (FDA) has issued a critical recall of blood pressure medication, affecting thousands of bottles across the nation. This recall is a serious concern as it involves a potential cross-contamination with a different medication, ezetimibe, which is used to treat high cholesterol.
The affected products are Bisoprolol Fumarate and Hydrochlorothiazide tablets, manufactured and distributed by Glenmark Pharmaceuticals Inc. The recall report highlights a potential issue with 11,136 bottles, which could have been contaminated with ezetimibe. This contamination poses a significant health risk as ezetimibe is a different medication with its own set of uses and side effects.
The affected bottles include various pack sizes: 30-count, 100-count, and 500-count, with specific National Drug Codes. The lot numbers and expiration dates to be cautious of are: Lot 17232401 (exp 11/2025) and Lot 17240974 (exp 05/2026).
It is crucial for consumers to refrain from consuming the affected medication. The FDA has not yet provided a remedy for those who have already taken the contaminated pills, emphasizing the need for immediate action to prevent potential health complications.
This recall serves as a reminder of the importance of medication safety and the potential risks associated with pharmaceutical manufacturing. It highlights the need for stringent quality control measures to ensure that patients receive the correct medications.
